TCTMD

Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at

[TCTMD @TCTMD]

More than three years later, results for the ANTHEM-HFrEF trial of vagal nerve stimulation have been released. The study was initially halted by sponsor LivaNova despite the data and safety monitoring board (DSMB) urging its continuation. https://t.co/mLLBGdttaG

[TCTMD @TCTMD]

A new joint statement from @escardio and other groups advocates for the creation of women’s heart centers to address the undertreatment and underdiagnosis of CVD in women. https://t.co/ImlyPPS3OT

[TCTMD @TCTMD]

The novel transcatheter heart valve Myval for severe aortic stenosis has consistently demonstrated safety and efficacy comparable to contemporary balloon-expandable and self-expanding valves, based on 2-year data from the LANDMARK study. https://t.co/QkpZWpJ34d
#EuroPCR 2026

[TCTMD @TCTMD]

Meta-analysis: Prasugrel the Best P2Y12 Inhibitor After PCI? https://t.co/J3db8d9rK8

[Babar Basir @Babar_Basir]

Thanks to @TCTMD for allowing me to comment on the CHIP-BCIS3 hemodynamic substudy. @CHIP_BCIS3

It makes no sense to include LOPP which we first described in @JCardFail in pts w/ & w/o MCS. LOPP only occurs in the MCS group, not in the SOC arm.

https://t.co/MoLQh9RpBv

[Cardiovascular Research Foundation @crfheart]

✨ It's here — the Live Case Program at #NYValves2026!

Witness master operators in action as they showcase advanced techniques and cutting-edge technologies from leading centers around the world. 🫀🌎

Preview the lineup and secure your spot today! 👉 https://t.co/iuVEloGuJg

#CardioX #CardioTwitter #CardioEd #CardioResearch @Kalazizimd @bapat_savrtavr @BurkhoffMD @djc795 @npfam1 @igeorge1975 @jgranadacrf @AdamGreenbaumMD @hahn_rt @EdwinHoMD @TsuyoshiKaneko1 @SusheelKodaliMD @azeemlatib @MartyBLeon @TheDoctorMack @MVMadhavanMD @jamiemccabeMD @modine_thomas @tnazifMD @PopmaJeffrey @laurenranard @MarwanSaadMD @psorajja @GilbertTangMD @drnvanmieghem @vonBardelebenRS @PradeepYadavMD @mirvatalasnag @triciarawh @TCTConference @TCTMD @sbhci @Dr_ibrahimHarbi @CathWhisperer @caldera_99 @aelsab @mderdem3 @CAESmedmd @NadeenFaza @RaghavG_MD @evandrofilhobr @GiorgioMedranda @purviparwani @SaadUrRahman55 @LucySafi @ShariqShamimMD @Sticchi_Alex @ladyheart_md

[TCTMD @TCTMD]

The likelihood that patients with hypertension will stop taking their prescribed blood pressure lowering medications varies based on their drug regimen, according to a new meta-analysis. Adverse events have been falsely attributed to BP-lowering drugs, leaving patients undertreated. https://t.co/H25SEwLlE7

[TCTMD @TCTMD]

IVUS Use in CLTI: Multidisciplinary Survey Supports RCT to Gather Data https://t.co/emiTO4geok

[TCTMD @TCTMD]

Missed an episode of Heart Valve Matters? Listen to @AmiBhattMD talk with Kate Dalton about the challenges of early feasibility studies. And catch our other episode “Critical importance of EFS to US Clinical Community with Martin Leon,” both available now. https://t.co/mkWVnEfvhV

[TCTMD @TCTMD]

Critical importance of EFS to US Clinical Community with Martin Leon https://t.co/iNa6PEVQOV

[TCTMD @TCTMD]

Challenges of Early Feasibility Studies with Kate Dalton https://t.co/knu0brteks

[TCTMD @TCTMD]

For complex PCI, the Selution sirolimus-eluting balloon is considered safe and effective, making it an alternative strategy to systematic stenting, based on a subgroup analysis of the SELUTION De Novo trial. https://t.co/M6QMXVRKh2
#EuroPCR 2026

[TCTMD @TCTMD]

COX-2-Selective NSAIDs a Better Choice in DOAC-Treated AF Patients https://t.co/IgRqmC4ViF

[TCTMD @TCTMD]

On this episode of Talking Points @CMichaelGibson and Ruben de Winter discuss the PROCTOR trial, which compares clinical outcomes of native vessel versus SVG PCI for patients with prior CABG. https://t.co/XqqQOT0CHA

[TCTMD @TCTMD]

Heat-Related CVD Burden Predicted to Rise Exponentially by 2050 https://t.co/HXTui7MCa1

[TCTMD @TCTMD]

The PROCTOR Trial https://t.co/5ENye9Bk8Q

[Cardiovascular Research Foundation @crfheart]

⏰ Last call for savings! Be there as the global interventional cardiovascular community 🌐 unites at #TCT2026 to share bold ideas, unveil cutting-edge science, and shape the next era of patient care. 💥

Lock in early-bird rates when you register by June 3 | 1:59 PM EDT (UTC −4). 👉 https://t.co/Aa0GJkPzKa

#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD

[TCTMD @TCTMD]

Semaglutide Benefits Diabetic Patients Regardless of CVD Status: FLOW Subanalysis https://t.co/uyVymcrM56

[Cardiovascular Research Foundation @crfheart]

Trailblazing science debuts here! 🔥 Experience the transformational late-breaking research driving the future of structural heart disease at #NYValves2026. 🗽🫀

The full lineup of research is LIVE!💥 Check out what’s in store and secure your spot today! https://t.co/CshtvWA9ao

#CardioX #CardioTwitter #CardioEd #CardioResearch @Kalazizimd @bapat_savrtavr @BurkhoffMD @djc795 @npfam1 @igeorge1975 @jgranadacrf @AdamGreenbaumMD @hahn_rt @EdwinHoMD @TsuyoshiKaneko1 @SusheelKodaliMD @azeemlatib @MartyBLeon @TheDoctorMack @MVMadhavanMD @jamiemccabeMD @modine_thomas @tnazifMD @PopmaJeffrey @laurenranard @MarwanSaadMD @psorajja @GilbertTangMD @drnvanmieghem @vonBardelebenRS @PradeepYadavMD @mirvatalasnag @triciarawh @TCTConference @TCTMD @sbhci @Dr_ibrahimHarbi @CathWhisperer @caldera_99 @aelsab @mderdem3 @CAESmedmd @NadeenFaza @RaghavG_MD @evandrofilhobr @GiorgioMedranda @purviparwani @SaadUrRahman55 @LucySafi @ShariqShamimMD @Sticchi_Alex @ladyheart_md

[TCTMD @TCTMD]

Conference season was in full swing during the month of May, and many of the top stories came from meetings like EuroPCR. TCTMD highlights the most popular articles of the month. https://t.co/989YnQwwe1